Hospira Expands Recall of Propofol and Liposyn

Hospira is voluntarily expanding its recall of its Propofol Injectable Emulsion 1% and Liposyn products, including Liposyn II 10%, Liposyn II 20%, Liposyn III 10%, Liposyn III 20% and Liposyn III 30%, due to particulate matter found in some of the containers, according to an alert from the U.S. Food and Drug Administration.


The affected lot numbers are:

  • Propofol — lot numbers beginning with 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 82, 83, 84 and 85.   
  • Liposyn — lot numbers beginning with 72, 73, 74, 75, 76, 77, 78, 82, 83, 84 and 85.

The affected lots of propofol were distributed between March 2008 and April 2010. The affected lots of Liposyn were distributed between Dec. 2008 and April 2010.

Read the FDA's alert about the Hospira recall.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast